Member Info for Scharnhorst

Bear in mind though a purchase made now doesn’t qualify for the final divi as the shares went ex-dividend a week ago. Peanuts anyway with our purchases but going forward we’re locking in a decent divi if we hold long term. Let’s hope inflation gets back below target! I’ll be re-investing the final divi when it arrives.

Ha ha. I emptied my piggy bank before you.

Your 07:21 post didn’t age well jamrock. Directors didn’t fancy buying shares after their closed period so why should anyone else?

Agreed. Their biggest shareholder MERC is doing anything but!

The presentation was recorded. Usually they’re available on the investormeetcompany site within a day or two. I’ve chivvied them up in the past when there was a delay and they were responsive.
There was a good mock up of the tiered arrangement of tests on store shelves. More expensive DNA ‘susceptibility’ tests at the top, then ‘point in time’ blood tests’ for monitoring progress with lifestyle changes then ‘broad brush’ lateral flow tests as a cheap way of determining if more investigation is required. It looked a good way to organise things and all tied in with NHS working parameters. Penny seems hot on the female wellness market and thinks women will be the biggest customers, so with her marketing background and intuition I think we have the right person at the helm.
Soon we’ll also be able to go to the chemist and buy a discrete sexual health test - “Something for after the weekend sir?”
I like the strategy. They’re still expecting significant covid revenues through the autumn and winter so can continue to build the wellness testing in the background for main launch . I think they’re still at the slowly slowly catchy monkey stage.
I’m very encouraged and hope we’re onto a winner early doors.
As for share price performance it’s better than the FTSE aim all share. Valid to say poor performance down to general bad sentiment rather than poor company performance. I’m invested in MERC who are the main shareholders in MHC. The MERC share price is nearly exactly correlated downwards with the aim all share index despite the company being better positioned than the average aim share. I feel the pain but I grit my teeth and hold on for better times. ‘It’ll be reet in t’morning’ as mein alter Vater used to say.

Half the market cap is backed up by cash.

I’m with you there barchid. With ongoing private equity consolidation it’s eat or be eaten.

Yes, I can see why they’ve bought at that price.

During the presentation Julian Viggars said the following about their portfolio company myhealthchecked:
Mercia aren't represented on the board but they have informal discussions with directors.
Current share price doesn't do justice to the strength of management and progress made.
Mercia brought in the management team and know their capability.
The company has significant cash and is still trading well off covid.
They have new products and sensible ideas for driving customers to buy them.
Mercia are confident the management team will make a success of the business.
dyor

Under water at the moment but this will end better than das boot and bish bash bosh Boris. What were you English thinking electing that?

https://www.youtube.com/watch?v=G7K4YT2zZ5g

Anyone watching? I'm finding it's cutting out quite a bit but might be my connection. Anyway lots of good info in there. I'd hate to see them presenting bad results though :-)

I was thinking 0.3-0.6p final dividend depending on whether they were cautious or bullish about future prospects so 0.5p is good and FD says they can keep increasing the dividend due to recurring revenue from fund management. So full year divi yield is 2.7% and rising which is fine by me as I'm in for a significant capital gain with the divi as a bonus. Patience required as we've come to expect but they keep delivering and that will be recognized in due course. Priced at a 36% discount to NAV and fund management business on top. I enjoyed reading the report. MHC is the drag on the portfolio but, being listed, it has certainly been hit by adverse sentiment and I think their share price will recover.

We don’t know they have over 6m cash. The figure given is nearly 6 months old and they haven’t updated.

Looking good in the rear view mirror but more important to look through the windscreen.

Since the update RNS of January 24th I’ve assumed June with earlier announcement possible. The April chatter has proved to be a lot of wind.

That article was dated 21st January. The April comment wasn’t backed up in the RNS of 24th January which stated launch in H1.

We're not seeing much benefit for a series of positive announcements. Presumably due to Librae selling down and only PIs there to pick up the pieces.

yes, I have shares in MHC

My previous thread is mothballed as far as I’m concerned. Emotional attachment to a company is something I try my utmost to avoid so I don’t buy the directors are wonderful guff until they’ve demonstrated their ability over a period of years and with more than a covid windfall to show for their efforts. Compared to companies like ODX and ABDX it’s unarguable that they’ve done very well and that could be due to them being more astute and adept business people, but it could also be due to knowing better lever pullers in a rather shambolic if not corrupt looking government. ABDX in particular look to have been royally ripped off over non payment for work done but I’m sure I’ll never know what went on behind the scenes.